Three months following the first closing of its Series C financing, iThera Medical completed a second closing with Occident Ventures, BayBG and Falk Strascheg Holding raising the total volume of Series C by EUR 2 million to a total of EUR 9 million. Investors of the first closing include FLUXUNIT, the corporate venture capital arm of OSRAM, the Wachstumsfonds Bayern managed by Bayern Kapital, BayBG and Extorel. iThera will use the proceeds to accelerate and expand the clinical development of its breakthrough imaging technology, MSOT (multispectral optoacoustic tomography). The technology has the unique capability of visualizing optical contrast at high resolution (down to 10 µm) in deep tissue (up to 3 cm) and displaying the image in real time. It is already in use for preclinical and clinical research around the globe and under further development for diagnostic applications.
For further information see iThera’s website.